Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 47.40M | £ 43.11M | £ 43.14M | £ 35.88M | £ 35.52M |
Total Assets | £ 353.68M | £ 343.81M | £ 335.63M | £ 326.29M | £ 309.22M |
Total Debt | £ 33.32M | £ 33.32M | £ 33.11M | £ 32.91M | £ 32.94M |
Net Debt | £ -14.08M | £ -9.79M | £ -10.03M | £ -2.97M | £ -2.58M |
Total Liabilities | £ 114.30M | £ 113.06M | £ 110.19M | £ 109.97M | £ 104.18M |
Stockholders Equity | £ 239.23M | £ 230.58M | £ 225.28M | £ 216.18M | £ 204.92M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |